Indigo Naturalis (Qing Dai) Research

→ View Product Details

Introduction

Indigo Naturalis Qing Dai Research unveils a rich tapestry of historical and contemporary studies surrounding this ancient botanical substance. Indigo Naturalis (Qing Dai) is primarily derived from plants that have been traditionally utilized in East Asian herbal practices. Its long-standing application in medicinal contexts showcases its significance in traditional herbal preparations.

With the current scientific exploration into Indigo Naturalis, researchers are diving deeper into its biological mechanisms and traditional applications. This page intends to provide an overview of selected research related to Indigo Naturalis Qing Dai.

Traditional Background

Dating back centuries, Indigo Naturalis has a rich heritage within the realms of traditional East Asian herbal medicine, especially in Chinese and Japanese practices. Deriving from indigo-containing plants, it has been processed into a fine powder, serving as a vital ingredient for numerous herbal formulas. The growing interest in such botanical ingredients in recent years has sparked further scientific studies into the benefits and historical applications of Indigo Naturalis.

Overview of Scientific Research

Ongoing academic exploration has examined Indigo Naturalis in varied contexts, including:

• Clinical studies involving patients
• Laboratory research focusing on biological pathways
• Experimental studies conducted within controlled environments

These studies probe into the chemical constituents of Indigo Naturalis and their interactions with various biological systems.

Selected Research Studies

(1)

Maintenance Therapy Study

Title
Maintenance Efficacy of Oral Indigo Naturalis for Ulcerative Colitis: A Single-Center, Open-Label, Randomized, Controlled Study

Journal
Inflammatory Bowel Diseases (2024)

Study Design

• Single-center clinical study
• Open-label randomized controlled trial
• Evaluation of maintenance therapy

Overview

This pivotal study explored whether continued treatment with Indigo Naturalis could sustain remission in patients afflicted by ulcerative colitis. After achieving mucosal healing through initial therapy, participants were divided into two groups: one continued with Indigo Naturalis while the other discontinued treatment.

The results revealed striking differences in remission rates at the one-year mark, emphasizing the potential benefits of sustained therapy.

Study Results

Twenty patients participated, revealing:

• Remission rate of 90% in the continuous treatment group
• Remission rate of 20% in the discontinuation group

Such findings reinforce the clinical potential of Indigo Naturalis in managing ulcerative colitis.

Research Context

Indigo Naturalis has been investigated extensively across clinical trials for ulcerative colitis, reflecting growing scientific attention toward botanical ingredients and their properties.

Research continues to emphasize the necessity for long-term safety evaluations and clinical outcomes.

Reference

Matsuno Y. et al.
Maintenance Efficacy of Oral Indigo Naturalis for Ulcerative Colitis: A Single-Center, Open-Label, Randomized, Controlled Study.
Inflammatory Bowel Diseases. 2024.

Research Disclaimer

Information on this page is provided for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with healthcare professionals about medical conditions.

(2)

Multicenter Randomized Clinical Trial (Japan)

Title
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

Journal
Gastroenterology (2018)

Study Design

• Multicenter
• Randomized
• Double-blind
• Placebo-controlled clinical trial

A total of 86 patients with active ulcerative colitis participated, receiving varying doses of Indigo Naturalis or a placebo for eight weeks.

Study Outcomes

Clinical indicators highlighted the significant differences between Indigo Naturalis groups and placebo, reinforcing its therapeutic importance.

Safety Observations

Although some mild liver dysfunction was noted, further research is warranted to fully evaluate the safety profile of Indigo Naturalis.

Reference

Naganuma M. et al.
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis
Gastroenterology, 2018.

Research Disclaimer

This content is for educational and informational purposes only. It is not to be construed as medical advice. Seek professional guidance for health-related decisions.

Interested in Indigo Naturalis?

Explore our Indigo Naturalis product sourced from natural materials and shipped worldwide from Japan.

→ View Product Details